Lion Point Capital, LP Milestone Pharmaceuticals Inc. Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
A detailed history of Lion Point Capital, LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 1,654,154 shares of MIST stock, worth $3.56 Million. This represents 6.75% of its overall portfolio holdings.
Number of Shares
1,654,154
Previous 2,340,207
29.32%
Holding current value
$3.56 Million
Previous $3.09 Million
18.61%
% of portfolio
6.75%
Previous 6.61%
Shares
9 transactions
Others Institutions Holding MIST
# of Institutions
45Shares Held
28.7MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$10.7 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$7 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5.97 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.72 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$4.43 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $64.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...